Skip to search formSkip to main contentSkip to account menu

123I-IBZM

Known as: Iodine I 123 Iodobenzamide 
A radiopharmaceutical containing the dopamine D2/D3 receptor agonist iodobenzamide (IBZM) labeled with the radionuclide iodine I 123 with dopamine… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Summary.72 consecutive patients with suspected parkinsonian syndromes (PS) were studied by dopamine transporter (DAT) and D2… 
Highly Cited
2004
Highly Cited
2004
Extrapyramidal features may occur in spinocerebellar ataxias consistent with neuropathological evidence of nigrostriatal… 
Highly Cited
2000
Highly Cited
2000
UNLABELLED Evaluation of therapies for parkinsonism by dopamine receptor SPECT requires a reproducible, optimized quantitation… 
Highly Cited
2000
Highly Cited
2000
Abstract. Structural imaging suggests that traumatic brain injury (TBI) may be associated with disruption of neuronal networks… 
Review
2000
Review
2000
This paper reviews the use of neuroimaging in the diagnosis of dementia, especially Alzheimer's disease. Computed tomography is… 
Highly Cited
1998
Highly Cited
1998
We performed a prospective clinical follow up (mean follow up, 36 months; range, 24–56 months) of 65 patients with de novo… 
Highly Cited
1997
Highly Cited
1997
A major line of evidence that supports the hypothesis of dopamine overactivity in schizophrenia is the psychomimetic potential of… 
Review
1993
Review
1993
OBJECTIVE To measure D2 dopamine receptors in the striatum in patients with multiple system atrophy and progressive supranuclear… 
Highly Cited
1991
Highly Cited
1991
123I-(S-)-2-hydroxy-3-iodo-6-methoxy-N[(l-ethyl-2-pyrrolidinyl) methyl]-benzamide (123I-IBZM) is a highly selective CNS D2…